Effects of Red Wine on Cardiovascular Risk Factors in Humans

Fifty healthy human subjects are randomized to not to consume any alcohol at all or to drink 1 glass of red wine/day for women or 2 glasses for men for three months. Outcomes are changes in mood, blood lipids, insulin levels, markers of inflammation and effects on liver and body composition.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Subjects

Age range

25 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

healthy subjects
25 years of age and older

Exclusion criteria

alcoholic first degree relatives

Treatment and study plan

Red Wine

Dietary Supplement

intake of red wine on a daily basis

Primary outcomes

effects on laboratory variables, mood and body composition

Time frame: 3 months

changes in mood, blood lipids, insulin levels, markers of inflammation and effects on liver and body composition.

Secondary outcomes

effects on liver fat amount

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

University Hospital, Linkoeping

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Aug 7, 2009
Registry last updated: May 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed